Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | +3.38% |
|
+18.60% | +22.40% |
Jun. 28 | Transcript : OncoCyte Corporation - Shareholder/Analyst Call | |
Jun. 18 | OncoCyte Names Andrea James Chief Financial Officer | MT |
Financials (USD)
Sales 2024 * | 1.51M | Sales 2025 * | 4.83M | Capitalization | 40.9M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -20M | EV / Sales 2024 * | 27.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.47 x |
P/E ratio 2024 * |
-1.05
x | P/E ratio 2025 * |
-1.8
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.2% |
Latest transcript on OncoCyte Corporation
1 day | +3.38% | ||
1 week | +18.60% | ||
Current month | +3.73% | ||
1 month | +11.68% | ||
3 months | +4.44% | ||
6 months | -7.27% | ||
Current year | +22.40% |
![Extreme 2.59](/images/extremecours_fleche.png)
![Extreme 2.55](/images/extremecours_fleche.png)
![Extreme 2.285](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
![Extreme 2.08](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joshua Riggs
CEO | Chief Executive Officer | 42 | 20-07-31 |
Yuh-Min Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Ekkehard Schütz
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Last
BRD | Director/Board Member | 64 | 15-12-22 |
Louis Silverman
BRD | Director/Board Member | 65 | 22-11-29 |
Andy Arno
CHM | Chairman | 64 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 3.06 | +3.38% | 49,478 |
24-07-02 | 2.96 | +0.34% | 44,616 |
24-07-01 | 2.95 | 0.00% | 374,586 |
24-06-28 | 2.95 | +1.03% | 40,036 |
24-06-27 | 2.92 | +10.61% | 61,474 |
Delayed Quote Nasdaq, July 03, 2024 at 01:30 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.40% | 39.56M | |
-41.62% | 7.97B | |
+5.03% | 3.53B | |
-9.10% | 2.16B | |
-27.31% | 1.84B | |
-21.96% | 1.63B | |
+6.72% | 909M | |
+24.08% | 778M | |
-9.61% | 696M | |
-30.82% | 497M |
- Stock Market
- Equities
- OCX Stock